Antileishmanial activity and organ distribution of the antifungal drug Amphotericin-B in free and liposomised form have been studied in Balb/c mice infected with Leishmania donovani. Results indicate that Amphotericin-B in the liposomised form is significantly more active than the free form. This increase in the activity is perhaps related to the reduced drug toxicity rather than the altered drug distribution at the site of infection
In the present work amphotericin B (AmB) was formulated in tristearin-based solid lipid nanoparticle...
The efficacy of sodium stibogluconate against Leishmania donovani infections was markedly enhanced b...
Here we report the activity of liposomes comprising egg phosphatidylcholine (PC) and stearylamine (S...
Antileishmanial activity and organ distribution of the antifungal drug Amphotericin-B in free and li...
Visceral leishmaniasis is a neglected tropical disease that causes significant morbidity and mortali...
: Visceral leishmaniasis is a neglected tropical disease that causes significant morbidity and morta...
Leishmania parasite resides mainly in the liver and the spleen and multiplies. Effective therapy of ...
Fungisome® (F), a liposomal amphotericin B (AmB) product, is marketed in India as a safe and effecti...
The first description of a skin lesion, “Delhi button” dates back to Cunningham (1885) who reported ...
Fungisome® (F), a liposomal amphotericin B (AmB) product, is marketed in India as a safe and effecti...
Liposomal amphotericin B (AmB) or AmBisome® is the most effective and safe therapeutic agent for vis...
BackgroundThere is a continued need to develop effective and safe treatments for visceral leishmania...
The treatment of visceral leishmaniasis (VL) may be complicated by drug toxicity or intolerance, and...
Disfiguring skin lesions caused by several species of the Leishmania parasite characterize cutaneous...
Background: Liposomal amphotericin B (AmBisome®) as a treatment modality for visceral leishmaniasis ...
In the present work amphotericin B (AmB) was formulated in tristearin-based solid lipid nanoparticle...
The efficacy of sodium stibogluconate against Leishmania donovani infections was markedly enhanced b...
Here we report the activity of liposomes comprising egg phosphatidylcholine (PC) and stearylamine (S...
Antileishmanial activity and organ distribution of the antifungal drug Amphotericin-B in free and li...
Visceral leishmaniasis is a neglected tropical disease that causes significant morbidity and mortali...
: Visceral leishmaniasis is a neglected tropical disease that causes significant morbidity and morta...
Leishmania parasite resides mainly in the liver and the spleen and multiplies. Effective therapy of ...
Fungisome® (F), a liposomal amphotericin B (AmB) product, is marketed in India as a safe and effecti...
The first description of a skin lesion, “Delhi button” dates back to Cunningham (1885) who reported ...
Fungisome® (F), a liposomal amphotericin B (AmB) product, is marketed in India as a safe and effecti...
Liposomal amphotericin B (AmB) or AmBisome® is the most effective and safe therapeutic agent for vis...
BackgroundThere is a continued need to develop effective and safe treatments for visceral leishmania...
The treatment of visceral leishmaniasis (VL) may be complicated by drug toxicity or intolerance, and...
Disfiguring skin lesions caused by several species of the Leishmania parasite characterize cutaneous...
Background: Liposomal amphotericin B (AmBisome®) as a treatment modality for visceral leishmaniasis ...
In the present work amphotericin B (AmB) was formulated in tristearin-based solid lipid nanoparticle...
The efficacy of sodium stibogluconate against Leishmania donovani infections was markedly enhanced b...
Here we report the activity of liposomes comprising egg phosphatidylcholine (PC) and stearylamine (S...